This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Two Biopharmaceutical Companies Moving Markets on Friday

NEW YORK (TheStreet) -- Coronado Biosciences Inc (CNDO) exploded on news its pilot study of an oral drug to treat autism was successful. The micro-cap had added 27.5% to $2.27 by early afternoon of Friday's session.

The clinical trial studied the effect of CNDO-201 over a placebo in autistic patients and found a statistically-significant difference in favor of the Coronado-developed treatment.

"There is increasing evidence that immune dysregulation plays an important role in this developmental disorder and we are encouraged by the interim data from this pilot study," said CEO Dr. Harlan F. Weisman in a statement.

The study, still ongoing, is expected to yield final results by mid-2014.

Another biopharmaceutical market-mover on Friday, Insys Therapeutics (INSY - Get Report) tanked 15.9% to $37.95 by early afternoon.

A day earlier the Phoenix-based drugmaker said it had received a subpoena from the Office of Inspector General of the Department of Health and Human Services relating to an investigation of potential health violations. The court document requests information pertaining to Insys' sublingual spray Subsys, including the company's sales and marketing practices of the product.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
CNDO $3.03 -2.26%
INSY $53.39 0.00%
AAPL $128.95 0.00%
FB $78.99 0.00%
GOOG $537.90 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs